Can Hebei Yipin Pharmaceutical be listed successfully?

Hebei Yipin Pharmaceutical has a high technical strength and leading position in the domestic anesthesia field. The company has adopted the integrated development strategy of raw materials and preparations, and its products cover many key fields. Core products such as sevoflurane for inhalation, ropivacaine injection and flurbiprofen axetil have driven the rapid growth of income. They have laid a solid foundation for the company's listing and have strong market potential.